Head of DS8201 and DS alliance - Europe
AstraZeneca is one of the world’s most exciting bio-pharmaceutical companies. From scientists to sales, lab techs to legal, we’re on a mission to turn ideas into life-changing medicines that improve patients’ lives and benefit society. We’re constantly moving forward as a company – agile and purposeful in our work.
Who we are
We need great people who share our passion for science and have the drive and determination to meet the unmet needs of patients around the world. If you’re swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you’re our kind of person. We bring new kinds of teams together across business areas and geographies, to pursue discoveries beyond imagining. Your team at AstraZeneca is made up of a global network of individuals from our business as well as the wider scientific world. We continuously forge partnerships that help pursue world-class medicines in new ways, combining our people’s exceptional skills with those of people from all over the globe. We’re stronger because of our network of teams across the globe. We’re constantly learning and developing through the collaboration and communication between our people and a wide field of experts.
Oncology within AstraZeneca
AstraZeneca is committed to advancing the science of oncology to deliver life-changing medicines to patients most in need. With a combination-focused pipeline that exploits the power of four scientific platforms to help address unmet clinical needs in a host of cancers.
Immuno-oncology - using the body’s immune system to help fight cancer
Tumour drivers and resistance - developing therapies that target specific mutations to attack cancer cells
DNA damage repair - targeting the DNA repair process to block tumour cells’ ability to reproduce
Antibody-drug conjugates - arming antibodies with cancer- killing agents for specific tumour targeting
AstraZeneca’s robust Oncology pipeline includes investigational therapies in varied stages of clinical development, from recently approved products to earlier-stage molecules in clinical trials. The company aspires to transform the lives of cancer patients, working to eliminate cancer as a cause of death in the future. As of April, 2017 there were 15 Phase 3 registration studies, 16 Phase 2 studies and 27 Phase 1 studies. In addition, a further 10 studies were in Life Cycle Management.
Our differentiated strategy of combining IO Therapies is leading in key tumour types such as non-small cell lung cancer, head and neck cancer and bladder cancer, where combined checkpoint blockade will address a significant unmet need for patients who may not benefit from monotherapies. We believe our unique IO development program will play a critical role in continuing to redefine the cancer treatment paradigm, potentially replacing the need for chemotherapy.
For more information on our Oncology Clinical Trial Development Program, please visit: www.astrazenecaclinicaltrials.com
Head of DS-8201 Europe Launch Execution
We are currently recruiting a Head of DS-8201 & Daiichi Sankyo Alliance Europe , reporting to the VP, Head of Europe, Oncology.This role will ensure strong collaboration with the Oncology BUDs, for Europe 5 (France, Germany, Italy, Spain, UK), as well as Non OBU markets and Canada.
This role will Co-Lead with the Daichi Sankyo DS-8201 Europe Lead the EU JRCC to ensure there is a joint commercialization plan for the brand as determined by the DSI -AZ JCC and Collaboration agreement. This position will require outstanding leadership in all areas of franchise management, as well as alliance collaboration management.
He or she will develop and execute integrated business plans, in full collaboration with the Global Teams.
This role will also require demonstrated excellence in teamwork and collaboration.
Oversee Alliance plan implementation & prepare all elements for JCC (Commercialization Plan and budget),
Leads Europe alliance reviews, provides leadership and oversight on tumor and pan-tumor specific market research plans/needs, forecasting,
Responsible for maximizing, market penetration, profitability, and new indication launch uptake
Co Accountable for achieving sales and budget forecasts for DS-8201, Review and update revenue forecasts and review commercialization budget at least on a quarterly basis,
Review and discuss the commercialization activities of AZ and DSI and coordinate with respect to products promoted under collaboration, including pre-launch and post-launch activities,
Provide a strong vision and leadership to Oncology Europe.
Build a strong collaborative relationship with AZ & DSI European teams
Working effectively with cross-functional partners including global, medical affairs, market access, regulatory affairs, manufacturing, market analytics, etc to successfully navigate the internal and external environments and deliver value to our customers
Minimum 10 years’ pharmaceutical experience
Minimum 5 years’ oncology experience.
Oncology marketing and sales experience
Experience in product/indication launch, marketplace assessment, development of disease state / product strategy, product positioning and brand marketing
Strong leadership, problem solving, teamwork, analytical, written/verbal communication, and presentation skills
Experience with collaboration, influencing without authority and working successfully with cross-functional teams
Minimum 3 years’ people management experience
This position requires approximately 20% travel, and is based in Zug, Switzerland
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorisation and employment eligibility verification requirements.